The Teenage Experience with Mono Might Have a Worrying Follow-up

Mono’s Potential Long-Term Effects

Many people have experienced infectious mononucleosis, commonly known as mono, or know someone who has. A recent study suggests that this unpleasant infection may lead to more serious health issues in the future.

Researchers from the Mayo Clinic and other institutions looked into the long-term health of individuals diagnosed with mono linked to the Epstein-Barr virus (EBV). They discovered that those with a history of mono were three times more likely to develop multiple sclerosis than those who had never been infected. This finding may shed light on why only a small fraction of those with EBV end up with this debilitating disease.

“Our results add to the growing body of evidence linking EBV-positive IM infection to MS risk,” the researchers noted in their published paper in the journal Neurology Open Access.

Common Yet Rarely Dangerous

Recent research has provided substantial evidence that EBV, a type of herpesvirus, is a leading cause of MS. However, many questions still linger regarding the exact relationship between the two.

Essentially everyone contracts EBV at some point; after the infection, the virus remains dormant in the body. Nevertheless, not everyone falls ill from the initial infection, and only a small percentage—around 1%—develop MS.

Mono is often seen as the most recognized form of acute EBV-related illness. It’s estimated to affect about a quarter of those who catch the virus during their teenage or young adult years. Symptoms typically surface about a month after being exposed and include things like a rash resembling measles, extreme tiredness, sore throat, and headaches. Most individuals recover within weeks, though a few may take up to six months to feel normal again.

Various studies have indicated a connection between EBV-related mono and an increased likelihood of developing MS. However, previous research has mainly relied on self-reported cases of mono, which adds a layer of uncertainty to the findings.

In this new study, researchers analyzed the medical history of 4,721 individuals with mono confirmed by a positive EBV test, comparing them with a larger population of 14,163 people without mono, matched for age and other factors.

The follow-up period averaged six to eight years. Although instances of diagnosed MS were relatively uncommon in both groups, those with mono showed a significantly higher risk. Even after adjusting for factors like smoking or depression, the study found those with a history of mono were over three times more likely to develop MS.

The Importance of Prevention

While these findings seem to reinforce the connection between mono and the risk of developing MS, it’s essential to remember that most people with mono will never face this condition. More research is needed to clarify the complexities behind MS triggers.

However, the authors of the study emphasize the urgent need for effective vaccines to prevent EBV infections—or at least the types of infections that could potentially lead to MS.